Alvin Shih Founder of Imbria Pharmaceuticals Backed byRA Capital ManagementSV Health InvestorsEmily MinkowHouman AshrafianNikola TrbovicRichard Aldrich LinkedIn SourcesImbria Pharmaceuticals Raises $57.5M Series B Financing Round and Appoints Alvin Shih, MD as CEO — 2025-04 Browse all founders · Browse investors
